Background Venous thromboembolism is a frequent complication of COVID-19 infection.
Less than 50% of pulmonary embolism (PE) is associated with the evidence of deep venous …

COVID-19 has been associated with an increased risk of thrombotic events; however, the
reported incidence of deep vein thrombosis varies depending, at least in part, on the severity …

Background: Several studies suggest an increased incidence of thrombosis in COVID-19
patients. However, evidence on how to prevent and even treat it is scarce. The aim of this …

Objective The aim of this study was to evaluate the incidence of deep vein thrombosis (DVT)
of the lower limbs in patients hospitalized with COVID-19 pneumonia in a non-ICU setting …

High incidence of venous thromboembolic (VTE) events in coronavirus disease 2019
(COVID-19) patients has been reported despite pharmacologic thromboprophylaxis. We …

Background The rapid spread of the severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2), and coronavirus disease 2019 (COVID‐19), has caused more than 3.9 …

The association between coronavirus disease 2019 (COVID-19) pneumonia and venous
thrombotic disorders is still unclear. We assessed the association between COVID-19 …

Background High incidence of deep vein thrombosis (DVT) has been observed in patients
with acute respiratory distress syndrome (ARDS) caused by COVID-19 and those by …

Background Preliminary reports suggest a hypercoagulable state in COVID-19. Deep vein
thrombosis (DVT) is perceived as a frequent finding in hospitalized COVID-19 patients, but …

Objectives Several reports had observed a high risk of pulmonary embolism (PE) in patients
with coronavirus disease 2019 (COVID‐19), most of them in the intensive care unit …